Tom Hughes, CEO of soon-to-IPO Zafgen (LifeSciVC blog) $ICPT
Crowdsourcing medical decisions: Ethicists worry Josh Hardy case may set bad precedent
Ariana Eunjung Cha (Washington Post) $CMRX
How to Read a Scientific Journal Article
American Association for Cancer Research (AACR)
The Feuerstein-Ratain Rule Update: Still Perfect Predicting Small-Cap Cancer Drug Failure
Adam Feuerstein (TheStreet) $OGXI
ASCO Proposes Innovative Patient-Centered Payment System for Cancer Care
American Society for Clinical Oncology weighs in on drug pricing.
Scientific method: Statistical errors
P values, the 'gold standard' of statistical validity, are not as reliable as many scientists assume.
Regina Nuzzo (Nature)
NPS Pharma’s Francois Nader on the Megadeal Fallout for Biotechs
Ben Filder (Xconomy) $NPSP $PFE $AZN
Biotech Due Diligence: Deconstructing the Milestone Calendar
David Sable (Forbes)
Great title, obviously.